Evaluation of the Safety of Bilateral Same-Day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents: Experience of a Large Korean Retina Center
Kyuhwan Jang,1 Jayoung Ahn,1 Joonhong Sohn,1 Daniel Duck-Jin Hwang1,2 1Department of Ophthalmology, HanGil Eye Hospital, Incheon, Korea; 2Department of Ophthalmology, Catholic Kwandong University College of Medicine, Incheon, KoreaCorrespondence: Daniel Duck-Jin HwangDepartment of Ophthalmology, Han...
Guardado en:
Autores principales: | Jang K, Ahn J, Sohn J, Hwang DDJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c366e83ca8148b9b6d727ae156d86af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão M, et al.
Publicado: (2017) -
Immediate sequential bilateral intravitreal injections: an Indian perspective
por: Tripathy K
Publicado: (2017) -
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda SM, et al.
Publicado: (2017) -
Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis
por: Kiss S, et al.
Publicado: (2018) -
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
por: Nudleman E, et al.
Publicado: (2016)